Clinical Trial: 20189

Trial Status: Open
Disease Type: Esophageal/Gastric
Trial ID 20189
Sponsor ID Incyte/ IQVIA

A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy (POD1UM-303/InterAACT 2) (INCMGA 0012-303)

Principal Investigator
Ajay Dar, MD

Locations

Loudoun Office

Learn More About This Trial
Other Relevant Trials
Trial ID AT148006
Sponsor ID ASPEN-06

A PHASE 2/3 STUDY OF ALX148 IN PATIENTS WITH ADVANCED HER2-OVEREXPRESSING GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA (ASPEN-06)

Principal Investigator
Samuel Lee, MD
Trial ID SGN-PDL1V
Sponsor ID SGNPDL1V-001

A Phase 1 Study of SGN-PDL1V in Advanced Solid Tumors